Combined hyperlipidemia in relation to race/ethnicity, obesity, and insulin resistance in the Multi-Ethnic Study of Atherosclerosis

Metabolism: Clinical and Experimental

Volumn 58, Issue 2, 2009, Pages 212-219

  Paramsothy, Pathmaja ^a   Knopp, Robert ^b   Bertoni, Alain G ^c   Tsai, Michael Y ^d   Rue, Tessa ^b   Heckbert, Susan R ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CAUCASIAN; CHINESE; CORONARY RISK; ETHNIC GROUP; FEMALE; HISPANIC; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RACE DIFFERENCE;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 58249093876     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.09.016     Document Type: Article

References (34)

1. The Lipid Research Clinics population studies data book, volume I: the prevalence study (1980), US Dept of Health and Human Services NIH publication 80-1527
2. Brindle P., May M., Gill P., et al. Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups. Heart 92 (2006) 1595-1602
3. Anand S.S., Yusuf S., Vuksan V., et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 356 (2000) 279-284
4. Razak F., Anand S.S., Shannon H., et al. Defining obesity cut points in a multiethnic population. Circulation 115 (2007) 2111-2118
5. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
6. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
7. Goldstein J.L., Schrott H.G., Hazzard W.R., Bierman E.L., and Motulsky A.G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52 (1973) 1544-1568
8. Brunzell J.D., Schrott H.G., Motulsky A.G., and Bierman E.L. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 25 (1976) 313-320
9. Austin M.A., McKnight B., Edwards K.L., et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 101 (2000) 2777-2782
10. Hopkins P.N., Heiss G., Ellison R.C., et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 108 (2003) 519-523
11. Veerkamp M.J., de Graaf J., Hendriks J.C., Demacker P.N., and Stalenhoef A.F. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation 109 (2004) 2980-2985
12. Knopp R.H., Walden C.E., Retzlaff B.M., et al. Long-term cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined hyperlipidemic men. The Dietary Alternatives Study. JAMA 278 (1997) 1509-1515
13. Walden C.E., Retzlaff B.M., Buck B.L., Wallick S., McCann B.S., and Knopp R.H. Differential effect of National Cholesterol Education Program (NCEP) Step II diet on HDL cholesterol, its subfractions, and apoprotein A-I levels in hypercholesterolemic women and men after 1 year: the beFIT Study. Arterioscler Thromb Vasc Biol 20 (2000) 1580-1587
14. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
15. Veerkamp M.J., de Graaf J., and Stalenhoef A.F. Role of insulin resistance in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 25 (2005) 1026-1031
16. van der Kallen C.J., Voors-Pette C., Bouwman F.G., et al. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus. Atherosclerosis 164 (2002) 337-346
17. Skoumas J., Papadimitriou L., Pitsavos C., et al. Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia. Metabolism 56 (2007) 135-141
18. Ascaso J.F., Real J.T., Merchante A., Rodrigo A., and Carmena R. Lipoprotein phenotype and insulin resistance in familial combined hyperlipidemia. Metabolism 49 (2000) 1627-1631
19. Bredie S.J., Tack C.J., Smits P., and Stalenhoef A.F. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives. Arterioscler Thromb Vasc Biol 17 (1997) 1465-1471
20. Aitman T.J., Godsland I.F., Farren B., Crook D., Wong H.J., and Scott J. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 17 (1997) 748-754
21. Bild D.E., Bluemke D.A., Burke G.L., et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 156 (2002) 871-881
22. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
23. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157 (1997) 2413-2446
24. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
26. Demacker P.N., Hijmans A.G., Brenninkmeijer B.J., Jansen A.P., and van 't Laar A. Five methods for determining low-density lipoprotein cholesterol compared. Clin Chem 30 (1984) 1797-1800
27. McClelland RL, Kronmal RA, Haessler J, Blumenthal RS, Goff Jr, DC. Estimation of risk factor associations when the response is influenced by medication use: an imputation approach. Statistics in Medicine. Published online (epub ahead of press) in Wiley Interscience. (www.interscience.wiley.com) DOI: 10.1002/sim.3341.
28. Despres J.P., Couillard C., Gagnon J., et al. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 20 (2000) 1932-1938
29. Sumner A.E., Finley K.B., Genovese D.J., Criqui M.H., and Boston R.C. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 165 (2005) 1395-1400
30. Cabezas M.C., et al. Impaired fatty acid metabolism in familial combined hyperlipidemia. J Clin Invest 92 (1993) 160-168
31. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
32. Lear S.A., Toma M., Birmingham C.L., and Frohlich J.J. Modification of the relationship between simple anthropometric indices and risk factors by ethnic background. Metabolism 52 (2003) 1295-1301
33. Bonora E., Targher G., Alberiche M., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23 (2000) 57-63
34. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54 (2005) 3252-3257